For much of the past 10 days or so, ASX investors were on holidays. This was despite the market being open for trading on a handful of days, 3 between Christmas and New Year as well as every day this week except Monday (New Years' Day).
If you were on holidays, you likely missed some bad…
As the new calendar year begins, we thought we would share our top 4 predictions for the ASX in 2024.
We hope all investors have a Happy New Year, although we cannot guarantee a Happy New Year from betting on any of these instances happening - anything is possible in this business. At the same time,…
LiveTiles (ASX:LVT) formally entered into receivership about a month ago, ending a near-decade tenure on the ASX. It was a very eventful period, with the company's market capitalisation surpassing $250m at its all time high. Unfortunately, things all went downhill in the past couple of years, culminating in its receivership.
We won't comment on the toing…
Failed takeover deals can and do happen for various reasons.
Why takeover deals fail
Some deals are killed off quickly by the company giving a negative answer as soon as they let their shareholders know. Others are killed off by shareholders - either by vote or one or two large shareholders publicly expressing opposition to the…
Despite a subdued environment for dealmaking, there were some notable ASX corporate takeovers during the year. We thought as 2023 comes to an end, it was fitting to recap some of the top deals of the past 12 months.
6 of the top ASX corporate takeovers of 2023
Newcrest
Newcrest was and is one…
Manufacturing stocks, and companies generally, are stuck in a deep funk right now. Both Australian and US PMI (Purchasing Managers Index) have fallen by ~25% since mid-2021 (The Australian figure is Judo Bank's own calculation). The Australian Chamber of Commerce and Industry-Westpac industrial survey found that confidence is at levels not seen since the GFC,…
There's nothing like ASX small caps with big name backers, especially when they first join the company. Whether they join as investors, as directors or even just as strategic advisors, they inspire confidence that a company has something special - be it a mineral deposit, a medtech device or a fine piece of technology. Stocks…
The Healius ACL merger appears all but dead now that the ACCC blocked the plans. Even so, it was on shaky grounds long before the competition regulator showed its scepticism and it is not implausible that ACL may try again in 2024. Let's look at why the tie up failed to happen and whether or…
Rhythm Biosciences (ASX:RHY) is back to square one after a rollercoaster 3 years. Where did it all go wrong, and is there a way back?
All about Rhythm Biosciences
Your analyst first came across this company in September 2019, right in the middle of his journalist days. The context was a 'gathering over sandwiches'…
Australia's coal phase out could occur within 15 years - at least if you are to believe the Australian Energy Market Operator (AEMO). Few would deny that the eventual phase out was inevitable, although perhaps not this fast, especially since the war in Ukraine led to surging energy and hence coal prices. This begs the…
